HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule.

Abstract
A large family with dominantly inherited rhegmatogenous retinal detachment, premature arthropathy, and development of phalangeal epiphyseal dysplasia, resulting in brachydactyly was linked to COL2A1, the gene encoding proalpha1(II) collagen. Mutational analysis of the gene by exon sequencing identified a novel mutation in the C-propeptide region of the molecule. The glycine to aspartic acid change occurred in a region that is highly conserved in all fibrillar collagen molecules. The resulting phenotype does not fit easily into pre-existing subgroups of the type II collagenopathies, which includes spondyloepiphyseal dysplasia, and the Kniest, Strudwick, and Stickler dysplasias.
AuthorsA J Richards, J Morgan, P W P Bearcroft, E Pickering, M J Owen, P Holmans, N Williams, C Tysoe, F M Pope, M P Snead, H Hughes
JournalJournal of medical genetics (J Med Genet) Vol. 39 Issue 9 Pg. 661-5 (Sep 2002) ISSN: 1468-6244 [Electronic] England
PMID12205109 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Collagen Type II
  • DNA
Topics
  • Adult
  • Amino Acid Sequence
  • Base Sequence
  • Chondrodysplasia Punctata
  • Collagen Type II (genetics)
  • DNA (chemistry, genetics)
  • DNA Mutational Analysis
  • Family Health
  • Female
  • Hand Deformities, Congenital (genetics, pathology)
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation
  • Mutation, Missense
  • Osteochondrodysplasias (genetics, pathology)
  • Pedigree
  • Sequence Homology, Amino Acid
  • Vitreoretinopathy, Proliferative (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: